Literature DB >> 12212718

Secret pills: HIV-positive patients' experiences taking antiretroviral therapy in North Carolina.

Carol Golin1, Frederick Isasi, Jean Breny Bontempi, Eugenia Eng.   

Abstract

Understanding the barriers to antiretroviral adherence is a critical step in improving the effectiveness of HIV treatment and saving lives. We sought to assess, qualitatively, the experiences of HIV-positive persons taking antiretroviral therapy (ART) in North Carolina. Twenty-four people participated in one of six focus groups. A structured interview script included three questions (two open-ended) and eight probes. Each discussion was taped, transcribed, and content-analyzed. Three distinct themes emerged. First, many participants believed that taking ART was lifesaving but missed doses because they feared that taking them in public would reveal their HIV status. Second, as a result, participants often found it difficult to integrate their regimens into the most basic daily activities. Finally, participants stressed the importance of having open, ongoing dialogues about their treatment plans and privacy needs with a wide range of health care workers. Multidimensional, tailored interventions may help persons living with HIV overcome the stigma and other complex barriers they face in taking antiretroviral therapy.

Entities:  

Mesh:

Year:  2002        PMID: 12212718     DOI: 10.1521/aeap.14.5.318.23870

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  33 in total

1.  The impact of stigma on medication adherence among HIV-positive adolescent and young adult females and the moderating effects of coping and satisfaction with health care.

Authors:  Jaime Martinez; Gary Harper; Russell A Carleton; Sybil Hosek; Kelly Bojan; Gretchen Clum; Gretchen Glum; Jonathan Ellen
Journal:  AIDS Patient Care STDS       Date:  2011-12-07       Impact factor: 5.078

Review 2.  HIV and stigma: analysis and research program.

Authors:  Andrew H Kaplan; Anna Scheyett; Carol E Golin
Journal:  Curr HIV/AIDS Rep       Date:  2005-11       Impact factor: 5.071

Review 3.  How qualitative methods contribute to understanding combination antiretroviral therapy adherence.

Authors:  Andrea Sankar; Carol Golin; Jane M Simoni; Mark Luborsky; Cynthia Pearson
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

Review 4.  The utilization of testing and counseling for HIV: a review of the social and behavioral evidence.

Authors:  Carla Makhlouf Obermeyer; Michelle Osborn
Journal:  Am J Public Health       Date:  2007-08-29       Impact factor: 9.308

5.  HIV stigma as a barrier to retention in HIV care at a general hospital in Lima, Peru: a case-control study.

Authors:  Carla Valenzuela; Cesar Ugarte-Gil; Jorge Paz; Juan Echevarria; Eduardo Gotuzzo; Sten H Vermund; Aaron M Kipp
Journal:  AIDS Behav       Date:  2015-02

6.  A pilot study of delivering peer health messages in an HIV clinic via mobile media.

Authors:  Christopher Winstead-Derlega; Mary Rafaly; Sarah Delgado; Jason Freeman; Katherine Cutitta; Tony Miles; Karen Ingersoll; Rebecca Dillingham
Journal:  Telemed J E Health       Date:  2012-06-25       Impact factor: 3.536

Review 7.  Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States.

Authors:  Mary Clare Masters; Karen M Krueger; Janna L Williams; Lindsay Morrison; Susan E Cohn
Journal:  Expert Rev Clin Pharmacol       Date:  2019-12       Impact factor: 5.045

8.  Factors associated with self-reported adherence to antiretroviral therapy in a Tanzanian setting.

Authors:  Melissa H Watt; Suzanne Maman; Carol E Golin; Jo Anne Earp; Eugenia Eng; Shrikant I Bangdiwala; Mark Jacobson
Journal:  AIDS Care       Date:  2010-03

9.  Literacy, social stigma, and HIV medication adherence.

Authors:  Katherine R Waite; Michael Paasche-Orlow; Lance S Rintamaki; Terry C Davis; Michael S Wolf
Journal:  J Gen Intern Med       Date:  2008-06-19       Impact factor: 5.128

10.  "It's all the time in my mind": facilitators of adherence to antiretroviral therapy in a Tanzanian setting.

Authors:  Melissa H Watt; Suzanne Maman; Jo Anne Earp; Eugenia Eng; Philip W Setel; Carol E Golin; Mark Jacobson
Journal:  Soc Sci Med       Date:  2009-03-28       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.